SPOTLIGHT -
John J. Miller, MD, discusses the risks of untreated PTSD and the importance of implementing more therapeutic tools into treatment paradigms.
MDMA's FDA Pause: An Opportunity to Amplify Approved PTSD Treatments
David Hellerstein, MD: Psychedelic Treatments for Psychiatric Disorders
Exploring the Misuse of PTSD Diagnosis
Anne Marie Albano, PhD: A Conversation on the Spectrum of Anxiety
MDMA-Assisted Psychotherapy: The Science Is What Matters
Tango Without Touching: Defusing Pediatric PTSD in the Emergency Department